Massive haemorrhage is defined as the necessity of 3 or more packed red blood cells in one hour, the transfusion of 10 packed blood cells, the loss of the half of the blood volume, the loss of 4-5 cc/kg/h or more, and haemorrhage shock. Haemorrhage shock provokes changes in the bloodstream with celular and organic disfunction. In many cases massive transfusion is needed to stabilize the vital function. This massive transfusion can have serious side effects (infectious and immunologic and no immunologic reactions) and increase the morbidity and mortality. Massive transfusion protocols improve the survival in severe trauma injury patients. The transfusion of fixed rate of packed red blood cells, fresh frozen plasma and platelet concentrates have decreased the severity of trauma induced coagulopathy. Recently several studies have shown the benefit of massive transfusion protocols with high transfusion ratios (1:1:1 RBC:FFP:PLT) in mortality after severe trauma. So early and aggressive transfusion improve the outcomes and the resources. Massive Transfusion Protocol have been elaborated in the Hospital Universitario de Canarias with high transfusion ratios (1:1:1 RBC:FFP:PLT) . The goals of this protocol is to reduce the variability in the clinic experience, to reduce the transfusion necessities and to assure an safe treatment with blood products. So with this study the investigators will evaluate if the goals of this Protocol are followed and if the use of this Protocol is really safe and efficient.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
30
Application lMassive Transfusion Protocol
Complejo Universitario de Canarias
Laguna del Marquesado, Santa Cruz de Tenerife, Spain
RECRUITING30-day Mortality
Time frame: First 30 day after massive transfusion
Time to Hemostasis
Time to hemostasis refers to the time that the subject achieved hemorrhage control (anatomic hemostasis and resuscitation complete)following emergency department arrival.
Time frame: admission to hospital discharge or 30 days, whichever comes first
Incidence of Massive Transfusion Related Serious Adverse Events
Immunological reactions No immunological reactions
Time frame: 30 days
Severity of coagulopathy associated with high transfusion ratios
Time frame: 30 days post admission
Amount of Blood Products Given to Hemostasis
Time frame: 24 hours from randomization
Amount of Blood Products Given From Hemostasis to 24 Hours After
Time frame: 24 hours after admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.